Compile Data Set for Download or QSAR
maximum 50k data
Found 402 Enz. Inhib. hit(s) with all data for entry = 8612
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408288(5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-N-(1-(...)
Affinity DataIC50:  6nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408339(5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-N-(1-(...)
Affinity DataIC50:  6nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408335(N-(1-(2-chlorophenyl)cyclopropyl)-5-(5-(difluorome...)
Affinity DataIC50:  6nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408345(N-(1-(2-chloro-4-fluorophenyl)cyclopropyl)-5-(5-(d...)
Affinity DataIC50:  8nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408287(5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-N-(1-(...)
Affinity DataIC50:  9nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408359(N-(1-(5-chloro-2-fluorophenyl)cyclopropyl)-5-(5-(d...)
Affinity DataIC50:  14nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408320(US10357493, Example 38(+))
Affinity DataIC50:  15nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408340(5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-N-(1-(...)
Affinity DataIC50:  15nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408334(N-(1-(3-chlorophenyl)cyclopropyl)-5-(5-(difluorome...)
Affinity DataIC50:  15nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408390(US10357493, Example 106)
Affinity DataIC50:  16nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408380(US10357493, Example 98)
Affinity DataIC50:  16nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408332(5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-N-(1-(...)
Affinity DataIC50:  16nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408388(N-(2-((5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)...)
Affinity DataIC50:  16nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408400(N-(2-(4-(difluoromethoxy)-2-fluorophenyl)-2-((5-(5...)
Affinity DataIC50:  17nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408356(N-(1-(3-chloro-2-fluorophenyl)cyclopropyl)-5-(5-(d...)
Affinity DataIC50:  17nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408398(N-(2-(4-(difluoromethoxy)phenyl)-2-((5-(5-(difluor...)
Affinity DataIC50:  18nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408431(N-(2-(4-(difluoromethoxy)-2-fluorophenyl)-2-((5-(5...)
Affinity DataIC50:  18nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408357(5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-N-(1-(...)
Affinity DataIC50:  19nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408432(N-(2-(4-(difluoromethoxy)-2-fluorophenyl)-2-((5-(5...)
Affinity DataIC50:  19nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408338(5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-N-(1-(...)
Affinity DataIC50:  20nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408437(N-(2-((5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)...)
Affinity DataIC50:  20nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408376(US10357493, Example 91)
Affinity DataIC50:  21nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408300(US10357493, Example 20(+))
Affinity DataIC50:  21nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408342(5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-N-(1-(...)
Affinity DataIC50:  21nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408396(US10357493, Example 113)
Affinity DataIC50:  21nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408337(5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-N-(1-(...)
Affinity DataIC50:  22nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408343(5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-N-(1-(...)
Affinity DataIC50:  22nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408385(US10357493, Example 101(+))
Affinity DataIC50:  22nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408344(5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-N-(1-(...)
Affinity DataIC50:  22nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408434(N-(2-(4-(difluoromethoxy)-2-fluorophenyl)-2-((5-(5...)
Affinity DataIC50:  23nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408329(5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-N-(1-(...)
Affinity DataIC50:  23nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408336(5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-N-(1-(...)
Affinity DataIC50:  23nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408281(5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-N-(1-p...)
Affinity DataIC50:  23nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408365(US10357493, Example 80)
Affinity DataIC50:  23nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408469(N-(2-(4-chlorophenyl)-2-((5-(5-(difluoromethyl)-1,...)
Affinity DataIC50:  24nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408410(N-(3-((5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)...)
Affinity DataIC50:  26nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408391(N-(2-((5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)...)
Affinity DataIC50:  27nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408330(N-(1-(4-bromophenyl)cyclopropyl)-5-(5-(difluoromet...)
Affinity DataIC50:  27nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408371(US10357493, Example 86)
Affinity DataIC50:  28nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408393(N-(2-((5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)...)
Affinity DataIC50:  28nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408347(N-(1-(6-bromopyridin-3-yl)cyclopropyl)-5-(5-(diflu...)
Affinity DataIC50:  28nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408360(N-(1-(2-chloro-3-methylphenyl)cyclopropyl)-5-(5-(d...)
Affinity DataIC50:  28nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408381(US10357493, Example 99-R)
Affinity DataIC50:  28nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408319(N-(2-((5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)...)
Affinity DataIC50:  29nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408314(N-(1-(4-(difluoromethoxy)-2-fluorophenyl)cycloprop...)
Affinity DataIC50:  29nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408459(N-(2-((5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)...)
Affinity DataIC50:  29nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408403(N-(2-((5-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)...)
Affinity DataIC50:  29nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408373(US10357493, Example 88)
Affinity DataIC50:  29nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408383(US10357493, Example 100(+))
Affinity DataIC50:  30nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
Selenity Therapeutics (Bermuda)

US Patent
LigandPNGBDBM408291(US10357493, Example 13(+))
Affinity DataIC50:  30nMAssay Description:All enzymatic reactions were conducted in duplicate at room temperature for 17 hours in a 50 μl mixture containing HDAC assay buffer (50 mM Tris...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 402 total ) | Next | Last >>
Jump to: